ARCHIVES

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

This article is from The Cancer Letter archive.

Vol. 20 No. 37 | September 30, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

CTEP Drafts FDA Approval Guidelines

March 4, 1988